Izabela Dolata

Statistics

Publications

Citations

143

H-Index

Active since

2017

Affiliations

Postgraduate School of Molecular Medicine(Current)

Izabela Dolata is an author at Postgraduate School of Molecular Medicine specializing in oncogenic signaling pathways, pharmacology, and molecular oncology.

Publications per year

2017–2018

Publications

SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains

Tomasz Rzymski, Michał Mikuła, Eliza Żyłkiewicz et al. · Oncotarget · 2017 · 107 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia

Wojciech Czardybon, Renata Windak, Aniela Gołas et al. · Oncotarget · 2018 · 36 citations · Full text

Medicine, Oncology, Pharmacology +14

1–2 of 2